AMP Capital Investors’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-1,259,247
| Closed | -$54.2M | – | 775 |
|
|
2021
Q3 | $54.2M | Sell |
1,259,247
-195,847
| -13% | -$8.68M | 0.3% | 76 |
|
|
2021
Q2 | $57M | Sell |
1,455,094
-27,045
| -2% | -$1.05M | 0.27% | 88 |
|
|
2021
Q1 | $53.7M | Buy |
1,482,139
+150,646
| +11% | +$5.35M | 0.27% | 90 |
|
|
2020
Q4 | $48.9M | Sell |
1,331,493
-414,778
| -24% | -$15.2M | 0.26% | 91 |
|
|
2020
Q3 | $59.9M | Sell |
1,746,271
-84,844
| -5% | -$2.97M | 0.35% | 58 |
|
|
2020
Q2 | $56.7M | Sell |
1,831,115
-105,651
| -5% | -$3.59M | 0.36% | 62 |
|
|
2020
Q1 | $60M | Sell |
1,936,766
-154,125
| -7% | -$5.25M | 0.44% | 43 |
|
|
2019
Q4 | $77.2M | Buy |
2,090,891
+18,732
| +0.9% | +$667K | 0.42% | 46 |
|
|
2019
Q3 | $71.2M | Sell |
2,072,159
-156,938
| -7% | -$5.71M | 0.4% | 57 |
|
|
2019
Q2 | $91.9M | Sell |
2,229,097
-172,523
| -7% | -$6.85M | 0.51% | 46 |
|
|
2019
Q1 | $96.4M | Buy |
2,401,620
+184,657
| +8% | +$7.4M | 0.54% | 40 |
|
|
2018
Q4 | $90.4M | Buy |
2,216,963
+73,544
| +3% | +$3.05M | 0.57% | 38 |
|
|
2018
Q3 | $89.3M | Buy |
2,143,419
+58,843
| +3% | +$2.27M | 0.49% | 40 |
|
|
2018
Q2 | $71.8M | Sell |
2,084,576
-46,560
| -2% | -$1.59M | 0.4% | 58 |
|
|
2018
Q1 | $71.4M | Sell |
2,131,136
-77,245
| -3% | -$2.66M | 0.4% | 58 |
|
|
2017
Q4 | $75.9M | Sell |
2,208,381
-103,984
| -4% | -$3.55M | 0.41% | 57 |
|
|
2017
Q3 | $78.3M | Sell |
2,312,365
-71,447
| -3% | -$2.3M | 0.44% | 54 |
|
|
2017
Q2 | $76.1M | Sell |
2,383,812
-57,576
| -2% | -$1.82M | 0.45% | 54 |
|
|
2017
Q1 | $79.6M | Sell |
2,441,388
-41,773
| -2% | -$1.32M | 0.47% | 51 |
|
|
2016
Q4 | $76.5M | Sell |
2,483,161
-198,696
| -7% | -$6.07M | 0.46% | 51 |
|
|
2016
Q3 | $84.8M | Sell |
2,681,857
-22,588
| -0.8% | -$755K | 0.52% | 45 |
|
|
2016
Q2 | $89.8M | Buy |
2,704,445
+37,195
| +1% | +$1.19M | 0.6% | 36 |
|
|
2016
Q1 | $76.1M | Sell |
2,667,250
-207,089
| -7% | -$5.92M | 0.51% | 48 |
|
|
2015
Q4 | $89.3M | Sell |
2,874,339
-204,090
| -7% | -$6.42M | 0.61% | 34 |
|
|
2015
Q3 | $90.6M | Buy |
3,078,429
+18,475
| +0.6% | +$592K | 0.66% | 27 |
|
|
2015
Q2 | $97.5M | Sell |
3,059,954
-4,549
| -0.1% | -$148K | 0.63% | 32 |
|
|
2015
Q1 | $102M | Sell |
3,064,503
-323,799
| -10% | -$10.3M | 0.62% | 32 |
|
|
2014
Q4 | $101M | Sell |
3,388,302
-518,668
| -13% | -$14.9M | 0.62% | 30 |
|
|
2014
Q3 | $110M | Buy |
3,906,970
+129,326
| +3% | +$3.63M | 0.7% | 17 |
|
|
2014
Q2 | $106M | Sell |
3,777,644
-8,616
| -0.2% | -$246K | 0.66% | 22 |
|
|
2014
Q1 | $115M | Sell |
3,786,260
-69,372
| -2% | -$2.07M | 0.77% | 16 |
|
|
2013
Q4 | $112M | Buy |
3,855,632
+146,004
| +4% | +$4.25M | 0.79% | 13 |
|
|
2013
Q3 | $102M | Buy |
3,709,628
+193,837
| +6% | +$5.27M | 0.78% | 20 |
|
|
2013
Q2 | $94M | Buy |
+3,515,791
| New | +$97.1M | 0.73% | 22 |
|
Other funds holding PFE
AMP Capital Investors's PFE Position: Q4 2021 in Review
AMP Capital Investors sold out of Pfizer (PFE) in Q4 2021, closing a stake of 1,259,247 shares — an estimated $54.2M sold.
AMP Capital Investors first reported a position in PFE in Q2 2013 and held it in 34 quarters. The position peaked at $115M in Q1 2014. 3,263 funds tracked by Wall St. Rank hold PFE as of Q4 2021.
- AMP Capital Investors reported no remaining Pfizer position as of Q4 2021 after selling out during the quarter.
- AMP Capital Investors sold 1,259,247 Pfizer shares in Q4 2021, an estimated $54.2M.
- AMP Capital Investors first reported a position in Pfizer in Q2 2013 and held it in 34 quarters.
- AMP Capital Investors's Pfizer position peaked at $115M in Q1 2014.
- 3,263 funds tracked by Wall St. Rank held Pfizer as of Q4 2021.
Based on AMP Capital Investors's 13F filing for Q4 2021, filed 14 Feb 2022.